glutathione effect on ovarian cancer

glutathione effect on ovarian cancer in Cancer: A Double-Edged Sword Glutathione as a Prognostic Biomarker

Name: glutathione effect on ovarian cancer in Cancer: A Double-Edged Sword Glutathione as a Prognostic Biomarker
Brand: condeoeiras.edu.pt
SKU: 66043385457
Price: 24.93 USD
Availability: InStock
Rating: 4.6084000000000005 (11 reviews)

Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer Role of Glutathione in Cancer Progression and Chemoresistance PMC Multi Omics Analysis Reveals Chronic Cisplatin Exposure Is Associated with Metabolic Rewiring Toward Glutathione Metabolism to Support Redox Adaptation in High Grade Serous Ovarian Cancer Glutathione: Lights and Shadows in Cancer Patients PMC International Journal of Oncology Involvement of glutathione peroxidases in the occurrence and development of breast cancers Journal of Translational Medicine Springer Nature Link

SKU: 66043385457 · From condeoeiras.edu.pt

4.6

USD24.93 USD55.93

Pay in 4 interest-free payments of $6.23 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11

doi: 10.1007/s00394-014-0706-z 2 Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P

C.CassuriagaJ.AltR.RedigL.et al (2023)

doi: 10.1016/j.brainresbull.2012.09.005

Nucleotide-binding oligomerization domain containing 2 (NOD2) is the first confirmed susceptibility gene for CD, and its mutation is significantly associated with the risk of CD onset [175, 176]